Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

þ  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

OF 1934

For the quarterly period ended January 25, 2013.

Or

¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

OF 1934

For the transition period from                          to                         

Commission file number 1-6357

 

LOGO

ESTERLINE TECHNOLOGIES CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   13-2595091
(State or other Jurisdiction   (I.R.S. Employer
of incorporation or organization)   Identification No.)

500  108th Avenue N.E., Bellevue, Washington 98004

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code (425) 453-9400

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    

Yes  þ    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    

Yes  þ    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

     Large accelerated filer  þ      Accelerated filer  ¨      Non-accelerated filer  ¨      Smaller reporting company  ¨

                                     (Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    

Yes  ¨    No  þ

As of February 26, 2013, 30,989,131 shares of the issuer’s common stock were outstanding.


PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEET

As of January 25, 2013 and October 26, 2012

(In thousands, except share amounts)

 

 

                                                         
         January 25,    
2013
        October 26,    
2012
 

ASSETS

     (Unaudited)     

Current Assets

    

Cash and cash equivalents

   $ 202,776      $ 160,675   

Cash in escrow

     5,017        5,016   

Accounts receivable, net of allowances

of $9,263 and $9,029

     331,335        383,362   

Inventories

    

Raw materials and purchased parts

     155,481        146,390   

Work in process

     178,729        174,824   

Finished goods

     87,416        88,623   
  

 

 

   

 

 

 
     421,626        409,837   

Income tax refundable

     6,516        4,832   

Deferred income tax benefits

     47,430        46,000   

Prepaid expenses

     27,207        21,340   

Other current assets

     6,083        4,631   
  

 

 

   

 

 

 

Total Current Assets

     1,047,990        1,035,693   

Property, Plant and Equipment

     715,584        701,541   

Accumulated depreciation

     358,611        345,140   
  

 

 

   

 

 

 
     356,973        356,401   

Other Non-Current Assets

    

Goodwill

     1,105,656        1,098,962   

Intangibles, net

     599,396        609,045   

Debt issuance costs, net of accumulated

amortization of $5,046 and $4,577

     8,349        8,818   

Deferred income tax benefits

     97,758        97,952   

Other assets

     19,282        20,246   
  

 

 

   

 

 

 
   $ 3,235,404      $ 3,227,117   
  

 

 

   

 

 

 

 

2


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED BALANCE SHEET

As of January 25, 2013 and October 26, 2012

(In thousands, except share amounts)

 

         January 25,    
2013
        October 26,    
2012
 

LIABILITIES AND SHAREHOLDERS’ EQUITY

     (Unaudited)     

Current Liabilities

    

Accounts payable

   $ 103,315      $ 108,689   

Accrued liabilities

     259,014        269,553   

Credit facilities

     82        0   

Current maturities of long-term debt

     10,953        10,610   

Deferred income tax liabilities

     5,620        5,125   

Federal and foreign income taxes

     4,326        2,369   
  

 

 

   

 

 

 

Total Current Liabilities

     383,310        396,346   

Long-Term Liabilities

    

Credit facilities

     225,000        240,000   

Long-term debt, net of current maturities

     578,329        598,060   

Deferred income tax liabilities

     204,509        205,198   

Pension and post-retirement obligations

     143,475        132,074   

Other liabilities

     35,519        34,904   

Shareholders’ Equity

    

Common stock, par value $.20 per share,

      authorized 60,000,000 shares, issued and

      outstanding 30,960,812 and 30,869,390

     6,192        6,174   

Additional paid-in capital

     576,966        569,235   

Retained earnings

     1,145,467        1,120,356   

Accumulated other comprehensive loss

     (73,504     (85,284
  

 

 

   

 

 

 

Total Esterline shareholders’ equity

     1,655,121        1,610,481   

Noncontrolling interests

     10,141        10,054   
  

 

 

   

 

 

 

Total Shareholders’ Equity

     1,665,262        1,620,535   
  

 

 

   

 

 

 
   $ 3,235,404      $ 3,227,117   
  

 

 

   

 

 

 

 

3


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENT OF OPERATIONS

For the Three Month Periods Ended January 25, 2013 and January 27, 2012

(Unaudited)

(In thousands, except per share amounts)

 

                                                         
     Three Months Ended  
         January 25,    
2013
        January 27,    
2012
 

Net Sales

   $ 457,962      $ 470,882   

Cost of Sales

     297,617        312,801   
  

 

 

   

 

 

 
     160,345        158,081   

Expenses

    

Selling, general & administrative

     98,611        94,697   

Research, development & engineering

     23,076        26,395   
  

 

 

   

 

 

 

Total Expenses

     121,687        121,092   
  

 

 

   

 

 

 

Operating Earnings

     38,658        36,989   

Interest Income

     (101     (95

Interest Expense

     10,444        11,528   
  

 

 

   

 

 

 

Income Before Income Taxes

     28,315        25,556   

Income Tax Expense

     2,394        2,576   
  

 

 

   

 

 

 

Income Including Noncontrolling Interests

     25,921        22,980   

Income Attributable to Noncontrolling Interests

     (810     (192
  

 

 

   

 

 

 

Net Earnings Attributable to Esterline

   $ 25,111      $ 22,788   
  

 

 

   

 

 

 

Earnings Per Share Attributable to Esterline:

    

Basic Earnings Per Share

   $ .81      $ .74   

Diluted Earnings Per Share

     .80        .73   

Comprehensive Income (Loss)

   $ 36,891      $ (41,078)   

 

4


ESTERLINE TECHNOLOGIES CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS

For the Three Month Periods Ended January 25, 2013 and January 27, 2012

(Unaudited)

(In thousands)

 

                                                         
     Three Months Ended  
         January 25,    
2013
        January 27,    
2012
 

Cash Flows Provided (Used) by Operating Activities

    

Net earnings including noncontrolling interests

   $ 25,921      $ 22,980   

Adjustments to reconcile net earnings including
noncontrolling interests to net cash provided
(used) by operating activities:

    

Depreciation and amortization

     27,971        26,123   

Deferred income taxes

     (3,516     (7,619

Share-based compensation

     3,743        2,648   

Gain on sale of capital assets

     (51     (447

Working capital changes, net of effect of acquisitions:

    

Accounts receivable

     54,172        11,202   

Inventories

     (8,743     (2,439

Prepaid expenses

     (5,771     (2,275

Other current assets

     (1,658     670   

Accounts payable

     (6,683     (3,777

Accrued liabilities

     (9,783     (1,550

Federal and foreign income taxes

     161        2,781   

Other liabilities

     9,486        75   

Other, net

     1,297        (1,725
  

 

 

   

 

 

 
     86,546        46,647   

Cash Flows Provided (Used) by Investing Activities

    

Purchases of capital assets

     (12,253     (12,926

Proceeds from sale of capital assets

     51        447   

Escrow deposit

     (1     (6
  

 

 

   

 

 

 
     (12,203     (12,485

Cash Flows Provided (Used) by Financing Activities

    

Proceeds provided by stock issuance under employee stock plans

     3,671        1,379   

Excess tax benefits from stock options exercised

     335        6   

Dividends paid to noncontrolling interest

     (514     0   

Proceeds from credit facilities

     82        0   

Repayment of long-term debt

     (36,609     (31,385

Proceeds from government assistance

     650        7,942   
  

 

 

   

 

 

 
     (32,385     (22,058

Effect of Foreign Exchange Rates on Cash and Cash Equivalents

     143        (3,850
  

 

 

   

 

 

 

Net Increase in Cash and Cash Equivalents

     42,101        8,254   

Cash and Cash Equivalents – Beginning of Period

     160,675        185,035   
  

 

 

   

 

 

 

Cash and Cash Equivalents – End of Period

   $ 202,776      $ 193,289   
  

 

 

   

 

 

 

Supplemental Cash Flow Information

    

Cash paid for interest

   $ 2,830      $ 4,069   

Cash paid for taxes

     5,083        5,878   

 

5


ESTERLINE TECHNOLOGIES CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Three Month Periods Ended January 25, 2013 and January 27, 2012

 

1. The consolidated balance sheet as of January 25, 2013, the consolidated statement of operations for the three month periods ended January 25, 2013, and January 27, 2012, and the consolidated statement of cash flows for the three month periods ended January 25, 2013, and January 27, 2012, are unaudited but, in the opinion of management, all of the necessary adjustments, consisting of normal recurring accruals, have been made to present fairly the financial statements referred to above in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the above statements do not include all of the footnotes required for complete financial statements. The results of operations and cash flows for the interim periods presented are not necessarily indicative of results that can be expected for the full year.

 

2. The notes to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended October 26, 2012, provide a summary of significant accounting policies and additional financial information that should be read in conjunction with this Form 10-Q.

 

3. The timing of the Company’s revenues is impacted by the purchasing patterns of customers and, as a result, revenues are not generated evenly throughout the year. Moreover, the Company’s first fiscal quarter, November through January, includes significant holiday periods in both Europe and North America.

 

4. Basic earnings per share is computed on the basis of the weighted average number of shares outstanding during the year. Diluted earnings per share includes the dilutive effect of stock options and restricted stock units. Common shares issuable from employee stock plans that are excluded from the calculation of diluted earnings per share because they were anti-dilutive were 672,825 and 632,275 in the first fiscal quarter of 2013 and 2012, respectively. Shares used for calculating earnings per share are disclosed in the following table.

 

                                                         
(In thousands)    Three Months Ended  
         January 25,    
2013
           January 27,    
2012
 

Shares Used for Basic Earnings Per Share

     30,904           30,631   

Shares Used for Diluted Earnings Per Share

     31,423           31,157   
                                                         

 

5.  The Company’s comprehensive income (loss) is as follows:

 

                                                         
(In thousands)    Three Months Ended  
         January 25,    
2013
           January 27,    
2012
 

Net Earnings

   $ 25,111         $ 22,788   

Change in Fair Value of Derivative Financial Instruments,
Net of Tax (Expense) Benefit of $(224) and $1,479

     (46        (3,350

Change in Pension and Post-Retirement Obligations,
Net of Tax Benefit (Expense) of $55 and $(831)

     (151        1,494   

Foreign Currency Translation Adjustment

     11,977           (62,010
  

 

 

      

 

 

 

  Comprehensive Income (Loss)

   $ 36,891         $ (41,078
  

 

 

      

 

 

 

 

6


The Company’s accumulated other comprehensive loss is comprised of the following:

 

                                                         
(In thousands)          January 25,      
2013
            October 26,      
2012
 

Net unrealized gain on derivative contracts

   $ 1,577      $ 1,623   

Pension and post-retirement obligations

     (99,330     (99,179

Currency translation adjustment

     24,249        12,272   
  

 

 

   

 

 

 

Total accumulated other comprehensive loss

   $ (73,504   $ (85,284
  

 

 

   

 

 

 

 

6. The income tax rate was 8.5% compared with 10.1% for the first fiscal quarter of 2013 and 2012, respectively. In the first fiscal quarter of 2013, the Company recognized $3.7 million of discrete tax benefits principally related to the following items. The first item was approximately $1.5 million of tax benefits due to the retroactive extension of the U.S. federal research and experimentation credits. The second item was approximately $2.2 million of tax benefits related to the settlement of U.S. and foreign tax examinations. In the first fiscal quarter of 2012, the Company recognized $2.3 million of discrete tax benefits due to a change in French tax laws associated with the holding company structure and the financing of the Souriau acquisition. The income tax rate differed from the statutory rate in the first fiscal quarter of 2013 and 2012, as both years benefited from various tax credits and certain foreign interest expense deductions.

It is reasonably possible that within the next twelve months approximately $5.1 million of tax benefits associated with research and development tax credits, capital and operating losses that are currently unrecognized could be recognized as a result of settlement of examinations and/or the expiration of a statute of limitations.

 

7. Subsequent to period end, on February 4, 2013, the Company acquired the Gamesman Group (Gamesman) for approximately $39.9 million. Gamesman is a global supplier of input devices principally serving the gaming industry. Gamesman will be included in the Avionics & Controls segment.

 

8. As of January 25, 2013, the Company had three share-based compensation plans, which are described below. The compensation cost that has been charged against income for those plans for the first fiscal quarter of 2013 and 2012 was $3.7 million and $2.6 million, respectively. During the first fiscal quarter of 2013 and 2012, the Company issued 91,422 and 30,493 shares, respectively, under its employee stock plans.

Employee Stock Purchase Plan (ESPP)

The ESPP is a “safe-harbor” designed plan whereby shares are purchased by participants at a discount of 5% of the market value on the purchase date and, therefore, compensation cost is not recorded under the ESPP.

Employee Sharesave Scheme

The Company offers shares under its employee sharesave scheme for U.K. employees. This plan allows participants the option to purchase shares at a 5% discount of the market price of the stock as of the beginning of the offering period. The term of these options is three years. The sharesave scheme is not a “safe-harbor” design, and therefore, compensation cost is recognized on this plan. Under the sharesave scheme, option exercise prices are equal to the fair market value of the Company’s common stock on the date of grant. No options were granted during the first fiscal quarter of 2013 or 2012.

Equity Incentive Plan

Under the equity incentive plan, option exercise prices are equal to the fair market value of the Company’s common stock on the date of grant. The Company granted 237,700 options and 311,400 options in the three month periods ended January 25, 2013, and January 27, 2012, respectively. The weighted-average grant date fair value of options granted during the three-month periods ended January 25, 2013, and January 27, 2012, was $29.12 per share and $23.74 per share, respectively.

The fair value of each option granted by the Company was estimated using a Black-Scholes pricing model which uses the assumptions noted in the following table. The Company uses historical data to estimate volatility of the Company’s common stock, option exercise, and employee termination assumptions. The risk-free

 

7


rate for the contractual life of the option is based on the U.S. Treasury zero coupon issues in effect at the time of the grant.

 

                                                         
     Three Months Ended  
           January 25,      
2013
           January 27,      
2012
 

Risk-free interest rate

     0.79 – 1.88%         0.91 – 2.11%   

Volatility

     41.89 – 44.25%         41.62 – 44.29%   

Expected life (years)

     4.5 – 9.5            4.5 – 9.5      

Dividends

     0            0      

In December 2012, the Board of Directors and Compensation Committee approved restricted stock unit awards under the equity incentive plan. The Company granted 32,200 restricted stock units during the three-month period ended January 25, 2013. The weighted-average grant date fair value of restricted stock units granted during the three-month period ended January 25, 2013, was $62.52 per share. The fair value for each restricted stock unit granted by the Company is equal to the fair market value of the Company’s common stock on the date of grant. There were no restricted stock units granted in the three-month period ended January 27, 2012.

 

9. The Company’s pension plans principally include a U.S. pension plan maintained by Esterline and a non-U.S. plan maintained by CMC Electronics, Inc. (CMC). Components of periodic pension cost consisted of the following:

 

                                                         
(In thousands)    Three Months Ended  
           January 25,      
2013
          January 27,      
2012
 

Service cost

   $ 2,749      $ 2,402   

Interest cost

     4,317        4,646   

Expected return on plan assets

     (5,573     (5,327

Amortization of prior service cost

     21        10   

Amortization of actuarial loss

     3,412        2,575   
  

 

 

   

 

 

 

Net Periodic Cost

   $ 4,926      $ 4,306   
  

 

 

   

 

 

 

The Company’s principal post-retirement plans include non-U.S. plans, which are non-contributory healthcare and life insurance plans. The components of expense of these other retirement benefits consisted of the following:

 

                                                         
(In thousands)    Three Months Ended  
         January 25,    
2013
        January 27,    
2012
 

Service cost

   $ 259      $ 102   

Interest cost

     190        163   

Amortization of prior service cost

     (17     0   

Amortization of actuarial loss (gain)

     8        (7
  

 

 

   

 

 

 

Net Periodic Cost

   $ 440      $ 258   
  

 

 

   

 

 

 

 

10. In March 2011, the Company entered into a $460.0 million secured credit facility made available through a group of banks. The credit facility is secured by substantially all of the Company’s assets and interest is based on standard inter-bank offering rates. The credit facility expires in July 2016. The interest rate will range from LIBOR plus 1.5% to LIBOR plus 2.25% depending on the leverage ratios at the time the funds are drawn. At January 25, 2013, the Company had $225.0 million outstanding under the secured credit facility at an interest rate of LIBOR plus 1.75% or 1.96%.

In July 2011, the Company amended the secured credit facility to provide for a €125.0 million term loan (Euro Term Loan). The interest rate on the Euro Term Loan will range from Euro LIBOR plus 1.5% to Euro LIBOR

 

8


plus 2.25% depending on the leverage ratios at the time the funds are drawn. At January 25, 2013, the Company had €45.4 million outstanding or $61.2 million under the Euro Term Loan at an interest rate of Euro LIBOR plus 1.75% or 1.81%. The loan amortizes at 1.25% of the original principal balance quarterly through March 2016, with the remaining balance due in July 2016.

The fair value of the Company’s $250.0 million 7.0% Senior Notes due August 2020 was $277.5 million as of January 25, 2013, and October 26, 2012. The fair value of the Company’s $175.0 million 6.625% Senior Notes due March 2017 was $176.8 million and $181.3 million as of January 25, 2013, and October 26, 2012, respectively. The carrying amounts of the secured credit facility and Euro Term Loan due 2016 approximate fair value. Estimates of fair value for the Senior Notes are based on quoted market prices, and considered Level 2 inputs as defined in the fair value hierarchy, described in Note 11.

Government refundable advances consist of payments received from the Canadian government to assist in research and development related to commercial aviation. The repayment of this advance is based on year-over-year commercial aviation revenue growth at CMC beginning in 2014. Imputed interest on the advance was 5.01% at January 25, 2013.

 

11. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. An asset or liability’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The hierarchy of fair value measurements is described below:

Level 1 – Valuations are based on quoted prices that the Company has the ability to obtain in actively traded markets for identical assets and liabilities. Since valuations are based on quoted prices that are readily and regularly available in an active market or exchange traded market, a valuation of these instruments does not require a significant degree of judgment.

Level 2 – Valuations are based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market.

Level 3 – Valuations are based on model-based techniques for which some or all of the assumptions are obtained from indirect market information that is significant to the overall fair value measurement and which require a significant degree of management judgment.

 

9


The following table sets forth the Company’s financial assets and liabilities that were measured at fair value on a recurring basis by level within the fair value hierarchy at January 25, 2013, and October 26, 2012:

 

                                                         
(In thousands)    Level 2  
           January 25,      
2013
           October 26,      
2012
 

Assets:

     

Derivative contracts designated as hedging instruments

   $ 7,108       $ 7,753   

Derivative contracts not designated as hedging instruments

     1,908         1,387   

Embedded derivatives

     377         51   

Liabilities:

     

Derivative contracts designated as hedging instruments

   $ 1,794       $ 2,143   

Derivative contracts not designated as hedging instruments

     736         361   

Embedded derivatives

     264         470   

The Company’s embedded derivatives are the result of entering into sales or purchase contracts that are denominated in a currency other than the Company’s functional currency or the supplier’s or customer’s functional currency. The fair value is determined by calculating the difference between quoted exchange rates at the time the contract was entered into and the period-end exchange rate. These contracts are categorized as Level 2 in the fair value hierarchy.

The Company’s derivative contracts consist of foreign currency exchange contracts and interest rate swap agreements. These derivative contracts are over the counter and their fair value is determined using modeling techniques that include market inputs such as interest rates, yield curves, and currency exchange rates. These contracts are categorized as Level 2 in the fair value hierarchy.

 

12. The Company uses derivative financial instruments in the form of foreign currency forward exchange contracts and interest rate swap contracts for the purpose of minimizing exposure to changes in foreign currency exchange rates on business transactions and interest rates, respectively. The Company’s policy is to execute such instruments with banks the Company believes to be credit worthy and not to enter into derivative financial instruments for speculative purposes. These derivative financial instruments do not subject the Company to undue risk, as gains and losses on these instruments generally offset gains and losses on the underlying assets, liabilities, or anticipated transactions that are being hedged.

All derivative financial instruments are recorded at fair value in the Consolidated Balance Sheet. For a derivative that has not been designated as an accounting hedge, the change in the fair value is recognized immediately through earnings. For a derivative that has been designated as an accounting hedge of an existing asset or liability (a fair value hedge), the change in the fair value of both the derivative and underlying asset or liability is recognized immediately through earnings. For a derivative designated as an accounting hedge of an anticipated transaction (a cash flow hedge), the change in the fair value is recorded on the Consolidated Balance Sheet in Accumulated Other Comprehensive Income (AOCI) to the extent the derivative is effective in mitigating the exposure related to the anticipated transaction. The change in the fair value related to the ineffective portion of the hedge, if any, is immediately recognized in earnings. The amount recorded within AOCI is reclassified into earnings in the same period during which the underlying hedged transaction affects earnings.

The fair values of derivative instruments are presented on a gross basis, as the Company does not have any derivative contracts which are subject to master netting arrangements. The Company does not have any hedges with credit-risk-related contingent features or that required the posting of collateral as of January 25, 2013. The cash flows from derivative contracts are recorded in operating activities in the Consolidated Statement of Cash Flows.

 

10


Foreign Currency Forward Exchange Contracts

The Company transacts business in various foreign currencies which subjects the Company’s cash flows and earnings to exposure related to changes in foreign currency exchange rates. These exposures arise primarily from purchases or sales of products and services from third parties. Foreign currency forward exchange contracts provide for the purchase or sale of foreign currencies at specified future dates at specified exchange rates and are used to offset changes in the fair value of certain assets or liabilities or forecasted cash flows resulting from transactions denominated in foreign currencies. As of January 25, 2013, and October 26, 2012, the Company had outstanding foreign currency forward exchange contracts principally to sell U.S. dollars with notional amounts of $334.2 million and $358.4 million, respectively. These notional values consist primarily of contracts for the European euro, British pound sterling and Canadian dollar, and are stated in U.S. dollar equivalents at spot exchange rates at the respective dates.

Interest Rate Swaps

The Company manages its exposure to interest rate risk by maintaining an appropriate mix of fixed and variable rate debt, which over time should moderate the costs of debt financing. When considered necessary, the Company may use financial instruments in the form of interest rate swaps to help meet this objective. In November 2010, the Company entered into an interest rate swap agreement for $100.0 million on the $175.0 million Senior Notes due in 2017. The swap agreement exchanged the fixed interest rate of 6.625% for a variable interest rate on the $100.0 million of the principal amount outstanding. The variable interest rate is based upon LIBOR plus 4.865% and was 5.166% at January 25, 2013. The fair value of the Company’s interest rate swap was a $1.9 million asset at January 25, 2013, and was estimated by discounting expected cash flows using market interest rates. The Company records interest receivable and interest payable on interest rate swaps on a net basis. In December 2010, the Company entered into an interest rate swap agreement for $75.0 million on the $175.0 million Senior Notes due in 2017. The swap agreement exchanged the fixed interest rate of 6.625% for a variable interest rate on the $75.0 million of the principal amount outstanding. The variable interest rate is based upon LIBOR plus 4.47% and was 4.771% at January 25, 2013. The fair value of the Company’s interest rate swap was a $1.7 million asset at January 25, 2013, and was estimated by discounting expected cash flows using market interest rates. The Company recognized a net interest receivable of $1.2 million at January 25, 2013. On February 5, 2013, the $75.0 million interest rate swap agreement to exchange the fixed interest rate on the $175.0 million Senior Notes due in 2017 for a variable interest rate was called and is payable in 30 days.

Embedded Derivative Instruments

The Company’s embedded derivatives are the result of entering into sales or purchase contracts that are denominated in a currency other than the Company’s functional currency or the supplier’s or customer’s functional currency.

Net Investment Hedge

In July 2011, the Company entered into a Euro Term Loan for €125.0 million under the secured credit facility. The Company designated the Euro Term Loan a hedge of the investment in a certain French business unit. The foreign currency gain or loss that is effective as a hedge is reported as a component of other comprehensive income in shareholders’ equity. To the extent that this hedge is ineffective, the foreign currency gain or loss is recorded in earnings. There was no ineffectiveness since inception of the hedge.

 

11


Fair Value of Derivative Instruments

Fair values of derivative instruments in the Consolidated Balance Sheet at January 25, 2013, and October 26, 2012, consisted of:

(In thousands)                     
            
  Fair Value  
    

          Classification          

             January 25,      
2013
             October 26,      
2012
 

Foreign Currency Forward

Exchange Contracts:

            
   Other current assets      $ 4,797         $ 3,694   
   Other assets        547           1,294   
   Accrued liabilities        1,558           2,228   
   Other liabilities        972           276   

Embedded Derivative

Instruments:

   Other current assets      $ 377         $ 51   
   Accrued liabilities        189           148   
   Other liabilities        75           322   

Interest Rate Swaps:

   Long-term debt, net of current maturities      $ 3,672         $ 4,152   

 

The effect of derivative instruments on the Consolidated Statement of Operations for the first fiscal quarter in 2013 and 2012 consisted of:

   

(In thousands)                     
            
        January 25,                    January 27,       
    

  Location of Gain (Loss)  

       2013        2012  

Fair Value Hedges:

            

Interest rate swap contracts

   Interest Expense      $ 716         $ 567   

Embedded derivatives

   Sales        523           335   

Cash Flow Hedges:

            

Foreign currency forward exchange contracts:

            

Amount of gain (loss) recognized

in AOCI (effective portion)

   AOCI      $ 257         $ (4,727

Amount of gain (loss) reclassified

from AOCI into income

   Sales        (80        (101

Net Investment Hedges:

            

Euro term loan

   AOCI      $ (2,416      $ 10,747   

In each of the first fiscal quarters of 2013 and 2012, the Company recorded a loss of $0.9 million and a loss of $5.8 million on foreign currency forward exchange contracts that have not been designated as an accounting hedge, respectively. These foreign currency exchange losses are included in selling, general and administrative expense.

There was no significant impact to the Company’s earnings related to the ineffective portion of any hedging instruments during the first fiscal quarter of 2013 and 2012. In addition, there was no significant impact to the Company’s earnings when a hedged firm commitment no longer qualified as a fair value hedge or when a hedged forecasted transaction no longer qualified as a cash flow hedge during the first fiscal quarter of 2013.

Amounts included in AOCI are reclassified into earnings when the hedged transaction settles. The Company expects to reclassify approximately $2.0 million of net gain into earnings over the next 12 months. The maximum duration of the Company’s foreign currency cash flow hedge contracts at January 25, 2013, is 23 months.

 

12


13. Segment information:

Business segment information for continuing operations includes the segments of Avionics & Controls, Sensors & Systems and Advanced Materials.

 

(In thousands)   Three Months Ended  
          January 25,      
2013
               January 27,      
2012
 

Sales

      

Avionics & Controls

  $ 174,570         $ 179,572   

Sensors & Systems

    171,810           171,672   

Advanced Materials

    111,582           119,638   
 

 

 

      

 

 

 

Total Sales

  $ 457,962         $ 470,882   
 

 

 

      

 

 

 

Income from Operations

      

Avionics & Controls

  $ 18,589         $ 20,063   

Sensors & Systems

    19,001           6,815   

Advanced Materials

    17,644           23,073   
 

 

 

      

 

 

 

Segment Earnings

    55,234           49,951   

Corporate expense

    (16,576        (12,962

Interest income

    101           95   

Interest expense

    (10,444        (11,528
 

 

 

      

 

 

 
  $ 28,315         $ 25,556   
 

 

 

      

 

 

 

 

14. The following schedules set forth condensed consolidating financial information as required by Rule 3-10 of Securities and Exchange Commission Regulation S-X as of January 25, 2013, and October 26, 2012, and for the applicable periods ended January 25, 2013, and January 27, 2012, for (a) Esterline Technologies Corporation (the Parent); (b) on a combined basis, the current subsidiary guarantors (Guarantor Subsidiaries) of the secured credit facility, Senior Notes due 2017, and Senior Notes due 2020; and (c) on a combined basis, the subsidiaries that are not guarantors of the secured credit facility, Senior Notes due 2017, and Senior Notes due 2020 (Non-Guarantor Subsidiaries). The Guarantor Subsidiaries are direct and indirect wholly-owned subsidiaries of Esterline Technologies Corporation and have fully and unconditionally, jointly and severally, guaranteed the secured credit facility, the Senior Notes due 2017, and the Senior Notes due 2020.

 

13


Condensed Consolidating Balance Sheet as of January 25, 2013.

 

                                                                                                                            
(In thousands)                                 
     Parent      Guarantor
    Subsidiaries
    Non-
Guarantor

     Subsidiaries
         Eliminations     Total  

Assets

            

Current Assets

            

Cash and cash equivalents

   $ 36,613       $ 1,219      $ 164,944       $ 0      $ 202,776   

Cash in escrow

     5,017         0        0         0        5,017   

Accounts receivable, net

     214         123,411        207,710         0        331,335   

Inventories

     0         166,348        255,278         0        421,626   

Income tax refundable

     0         6,516        0         0        6,516   

Deferred income tax benefits

     22,761         111        24,558         0        47,430   

Prepaid expenses

     132         7,189        19,886         0        27,207   

Other current assets

     167         626        5,290         0        6,083   

 

 

    Total Current Assets

     64,904         305,420        677,666         0        1,047,990   

Property, Plant &

    Equipment, Net

     2,646         160,649        193,678         0        356,973   

Goodwill

     0         314,652        791,004         0        1,105,656   

Intangibles, Net

     0         122,609        476,787         0        599,396   

Debt Issuance Costs, Net

     7,126         0        1,223         0        8,349   

Deferred Income

   Tax Benefits

     36,014         (294     62,038         0        97,758   

Other Assets

     7,572         1,498        10,212         0        19,282   

Amounts Due From (To)
Subsidiaries

     0         527,892        0         (527,892     0   

Investment in Subsidiaries

     2,484,669         1,180,596        164,099         (3,829,364     0   

 

 

Total Assets

   $ 2,602,931       $ 2,613,022      $ 2,376,707       $ (4,357,256   $ 3,235,404   

 

 

 

14


                                                                                                                            
(In thousands)                                
     Parent     Guarantor
     Subsidiaries
    Non-
Guarantor

     Subsidiaries
         Eliminations     Total  

Liabilities and Shareholders’ Equity

  

      

Current Liabilities

           

Accounts payable

   $ 2,159      $ 26,491      $ 74,665       $ 0      $ 103,315   

Accrued liabilities

     22,884        79,321        156,809         0        259,014   

Credit facilities

     0        0        82         0        82   

Current maturities of

     long-term debt

     0        174        10,779         0        10,953   

Deferred income tax

     liabilities

     232        (1     5,389         0        5,620   

Federal and foreign
income taxes

     (251     (23,002     27,579         0        4,326   

 

 

Total Current Liabilities

     25,024        82,983        275,303         0        383,310   

Credit Facilities

     225,000        0        0         0        225,000   

Long-Term Debt, Net

     428,672        44,060        105,597         0        578,329   

Deferred Income Tax
Liabilities

     46,668        (6     157,847         0        204,509   

Pension and Post-
Retirement Obligations

     20,395        52,176        70,904         0        143,475   

Other Liabilities

     4,661        5,048        25,810         0        35,519   

Amounts Due To (From)
Subsidiaries

     187,249        0        380,690         (567,939     0   

Shareholders’ Equity

     1,665,262        2,428,761        1,360,556         (3,789,317     1,665,262   

 

 

Total Liabilities and
Shareholders’ Equity

   $ 2,602,931      $ 2,613,022      $ 2,376,707       $ (4,357,256   $ 3,235,404   

 

 

 

15


Condensed Consolidating Statement of Operations for the three month period ended January 25, 2013.

 

                                                                                                                            
(In thousands)                              
    Parent     Guarantor
    Subsidiaries
    Non-
Guarantor

     Subsidiaries
        Eliminations     Total  

Net Sales

  $ 0      $ 206,699      $ 252,170      $ (907   $ 457,962   

Cost of Sales

    0        131,866        166,658        (907     297,617   

 

 
    0        74,833        85,512        0        160,345   

Expenses

         

Selling, general
and administrative

    0        35,731        62,880        0        98,611   

Research, development

    and engineering

    0        11,058        12,018        0        23,076   

 

 

    Total Expenses

    0        46,789        74,898        0        121,687   

 

 

Operating Earnings

    0        28,044        10,614        0        38,658   

Interest Income

    (3,660     (1,717     (14,688     19,964        (101

Interest Expense

    8,081        6,321        16,006        (19,964     10,444   

 

 

Income (Loss) Before Taxes

    (4,421     23,440        9,296        0        28,315   

Income Tax Expense

    (Benefit)

    (950     2,446        898        0        2,394   

 

 

Income (Loss) Including

    Noncontrolling Interests

    (3,471     20,994        8,398        0        25,921   

Income Attributable to

    Noncontrolling Interests

    0        0        (810     0        (810

 

 

Income (Loss) Attributable

    to Esterline

    (3,471     20,994        7,588        0        25,111   

Equity in Net Income of

    Consolidated Subsidiaries

    28,582        658        0        (29,240     0   

 

 

Net Income (Loss)

    Attributable to Esterline

  $ 25,111      $ 21,652      $ 7,588      $ (29,240   $ 25,111   

 

 

 

16


Condensed Consolidating Statement of Cash Flows for the three month period ended January 25, 2013.

 

                                                                                                                            
(In thousands)                               
     Parent     Guarantor
     Subsidiaries
    Non-
Guarantor

     Subsidiaries
        Eliminations     Total  

Cash Flows Provided (Used)
by Operating Activities

          

Net earnings (loss) including
noncontrolling interests

   $ 25,921      $ 21,652      $ 7,588      $ (29,240   $ 25,921   

Depreciation & amortization

     0        10,076        17,895        0        27,971   

Deferred income taxes

     (284     6        (3,238     0        (3,516

Share-based compensation

     0        1,467        2,276        0        3,743   

Gain on sale of capital assets

     0        (32     (19     0        (51

Working capital changes, net
of effect of acquisitions:

          

Accounts receivable

     (33     17,220        36,985        0        54,172   

Inventories

     0        (6,775     (1,968     0        (8,743

Prepaid expenses

     (56     (1,798     (3,917     0        (5,771

Other current assets

     (33     (74     (1,551     0        (1,658

Accounts payable

     215        140        (7,038     0        (6,683

Accrued liabilities

     5,547        218        (15,548     0        (9,783

Federal & foreign
income taxes

     3,167        (1,212     (1,794     0        161   

Other liabilities

     1,840        (1,856     9,502        0        9,486   

Other, net

     (2,240     4,777        (1,240     0        1,297   

 

 
     34,044        43,809        37,933        (29,240     86,546   

Cash Flows Provided (Used)
by Investing Activities

          

Purchases of capital assets

     (21     (4,572     (7,660     0        (12,253

Proceeds from sale
of capital assets

     0        32        19        0        51   

Escrow deposit

     (1     0        0        0        (1

 

 
     (22     (4,540     (7,641     0        (12,203

 

17


                                                                                                                            
(In thousands)                                
     Parent     Guarantor
     Subsidiaries
    Non-
Guarantor

     Subsidiaries
        Eliminations      Total  

Cash Flows Provided (Used)
by Financing Activities

           

Proceeds provided by stock
issuance under employee
stock plans

     3,671        0        0        0         3,671   

Excess tax benefits from
stock options exercised

     335        0        0        0         335   

Dividends paid to
noncontrolling interest

     0        0        (514     0         (514

Proceeds from credit facilities

     0        0        82        0         82   

Repayment of long-term debt

     (15,000     (92     (21,517     0         (36,609

Proceeds from government
assistance

     0        0        650        0         650   

Net change in intercompany
financing

     (3,193     (39,324     13,277        29,240         0   

 

 
     (14,187     (39,416     (8,022     29,240         (32,385

Effect of foreign exchange
rates on cash and cash
equivalents

     8        42        93        0         143   

 

 

Net increase (decrease) in
cash and cash equivalents

     19,843        (105     22,363        0         42,101   

Cash and cash equivalents
– beginning of year

     16,770        1,324        142,581        0         160,675   

 

 

Cash and cash equivalents
– end of year

   $ 36,613      $ 1,219      $ 164,944      $ 0       $ 202,776   

 

 

 

18


Condensed Consolidating Balance Sheet as of October 26, 2012.

 

                                                                                                                            
(In thousands)                                 
     Parent      Guarantor
     Subsidiaries
    Non-
Guarantor

     Subsidiaries
         Eliminations     Total  

Assets

            

Current Assets

            

Cash and cash equivalents

   $ 16,770       $ 1,324      $ 142,581       $ 0      $ 160,675   

Cash in escrow

     5,016         0        0         0        5,016   

Accounts receivable, net

     181         140,631        242,550         0        383,362   

Inventories

     0         159,573        250,264         0        409,837   

Income tax refundable

     0         4,832        0         0        4,832   

Deferred income tax benefits

     22,874         105        23,021         0        46,000   

Prepaid expenses

     76         5,391        15,873         0        21,340   

Other current assets

     134         552        3,945         0        4,631   

 

 

Total Current Assets

     45,051         312,408        678,234         0        1,035,693   

Property, Plant &
Equipment, Net

     2,811         161,998        191,592         0        356,401   

Goodwill

     0         314,641        784,321         0        1,098,962   

Intangibles, Net

     0         126,142        482,903         0        609,045   

Debt Issuance Costs, Net

     7,508         0        1,310         0        8,818   

Deferred Income Tax
Benefits

     36,610         (283     61,625         0        97,952   

Other Assets

     8,082         1,561        10,603         0        20,246   

Amounts Due From (To)
Subsidiaries

     0         491,143        0         (491,143     0   

Investment in Subsidiaries

     2,457,859         1,179,938        170,223         (3,808,020     0   

 

 

Total Assets

   $ 2,557,921       $ 2,587,548      $ 2,380,811       $ (4,299,163   $ 3,227,117   

 

 

 

19


                                                                                                                            
(In thousands)                                
     Parent     Guarantor
     Subsidiaries
    Non-
Guarantor

     Subsidiaries
         Eliminations     Total  

Liabilities and Shareholders’ Equity

  

      

Current Liabilities

           

Accounts payable

   $ 1,944      $ 26,351      $ 80,394       $ 0      $ 108,689   

Accrued liabilities

     17,495        79,103        172,955         0        269,553   

Credit facilities

     0        0        0         0        0   

Current maturities of
long-term debt

     0        174        10,436         0        10,610   

Deferred income tax
liabilities

     213        (1     4,913         0        5,125   

Federal and foreign
income taxes

     (3,418     (23,822     29,609         0        2,369   

 

 

Total Current Liabilities

     16,234        81,805        298,307         0        396,346   

Credit Facilities

     240,000        0        0         0        240,000   

Long-Term Debt, Net

     429,152        44,107        124,801         0        598,060   

Deferred Income Tax
Liabilities

     46,730        (7     158,475         0        205,198   

Pension and Post-Retirement
Obligations

     20,507        54,886        56,681         0        132,074   

Other Liabilities

     5,189        4,194        25,521         0        34,904   

Amounts Due To (From)
Subsidiaries

     179,574        0        369,962         (549,536     0   

Shareholders’ Equity

     1,620,535        2,402,563        1,347,064         (3,749,627     1,620,535   

 

 

Total Liabilities and
Shareholders’ Equity

   $ 2,557,921      $ 2,587,548      $ 2,380,811       $ (4,299,163   $ 3,227,117   

 

 

 

20


Condensed Consolidating Statement of Operations for the three month period ended January 27, 2012.

 

                                                                                                                            
(In thousands)                               
     Parent     Guarantor
     Subsidiaries
    Non-
Guarantor

     Subsidiaries
        Eliminations     Total  

Net Sales

   $ 0      $ 214,243      $ 257,243      $ (604   $ 470,882   

Cost of Sales

     0        135,359        178,046        (604     312,801   

 

 
     0        78,884        79,197        0        158,081   

Expenses

          

Selling, general
and administrative

     0        34,893        59,804        0        94,697   

Research, development
and engineering

     0        11,076        15,319        0        26,395   

 

 

Total Expenses

     0        45,969        75,123        0        121,092   

 

 

Operating Earnings

     0        32,915        4,074        0        36,989   

Interest Income

     (3,477     (3,694     (17,491     24,567        (95

Interest Expense

     8,834        6,580        20,681        (24,567     11,528   

 

 

Income (Loss) Before Taxes

     (5,357     30,029        884        0        25,556   

Income Tax Expense
(Benefit)

     (997     3,373        200        0        2,576   

 

 

Income (Loss) Including
Noncontrolling Interests

     (4,360     26,656        684        0        22,980   

Income Attributable to
Noncontrolling Interests

     0        0        (192     0        (192

 

 

Income (Loss) Attributable
to Esterline

     (4,360     26,656        492        0        22,788   

Equity in Net Income of
Consolidated Subsidiaries

     27,148        10,094        (2,890     (34,352     0   

 

 

Net Income (Loss)
Attributable to Esterline

   $ 22,788      $ 36,750      $ (2,398   $ (34,352   $ 22,788   

 

 

 

21


Condensed Consolidating Statement of Cash Flows for the three month period ended January 27, 2012.

 

 

                                                                                                                            
(In thousands)                               
       Parent     Guarantor
    Subsidiaries
    Non-
Guarantor
    Subsidiaries
        Eliminations     Total  

Cash Flows Provided (Used)
by Operating Activities

          

Net earnings (loss) including
noncontrolling interests

   $ 22,980      $ 36,750      $ (2,398   $ (34,352   $ 22,980   

Depreciation & amortization

     0        9,561        16,562        0        26,123   

Deferred income taxes

     226        (34     (7,811     0        (7,619

Share-based compensation

     0        1,137        1,511        0        2,648   

Gain on sale of capital assets

     0        (54     (393     0        (447

Working capital changes, net
of effect of acquisitions:

          

Accounts receivable

     (97     13,070        (1,771     0        11,202   

Inventories

     0        (5,763     3,324        0        (2,439

Prepaid expenses

     (84     (1,369     (822     0        (2,275

Other current assets

     4        (4     670        0        670   

Accounts payable

     325        172        (4,274     0        (3,777

Accrued liabilities

     5,425        1,840        (8,815     0        (1,550

Federal & foreign
income taxes

     10,247        (732     (6,734     0        2,781   

Other liabilities

     1,965        (1,153     (737     0        75   

Other, net

     0        1,006        (2,731     0        (1,725

 

 
     40,991        54,427        (14,419     (34,352     46,647   

Cash Flows Provided (Used)
by Investing Activities

          

Purchases of capital assets

     (408     (7,285     (5,233     0        (12,926

Proceeds from sale
of capital assets

     0        54        393        0        447   

Escrow deposit

     (6     0        0        0        (6

 

 
     (414     (7,231     (4,840     0        (12,485

 

22


                                                                                                                            
(In thousands)                                
     Parent     Guarantor
    Subsidiaries
    Non-
Guarantor
    Subsidiaries
        Eliminations      Total  

Cash Flows Provided (Used) by Financing Activities

           

Proceeds provided by stock issuance under employee stock plans

     1,379        0        0        0         1,379   

Excess tax benefits from stock options exercised

     6        0        0        0         6   

Dividends paid to noncontrolling interest

     0        0        0        0         0   

Proceeds from credit facilities

     0        0        0        0         0   

Repayment of long-term debt

     (25,000     (114     (6,271     0         (31,385

Proceeds from government assistance

     0        0        7,942        0         7,942   

Net change in intercompany financing

     (18,214     (45,244     29,106        34,352         0   

 

 
     (41,829     (45,358     30,777        34,352         (22,058

Effect of foreign exchange rates on cash and cash equivalents

     0        (114     (3,736     0         (3,850

 

 

Net increase (decrease) in cash and cash equivalents

     (1,252     1,724        7,782        0         8,254   

Cash and cash equivalents
– beginning of year

     49,837        13,450        121,748        0         185,035   

 

 

Cash and cash equivalents
– end of year

   $ 48,585      $ 15,174      $ 129,530      $ 0       $ 193,289   

 

 

 

23


Item 2. Management’s Discussion and Analysis of Financial Condition and
   Results of Operations

Overview

We operate our businesses in three segments: Avionics & Controls, Sensors & Systems and Advanced Materials. Our segments are structured around our technical capabilities.

The Avionics & Controls segment includes avionics systems, control systems, interface technologies and communication systems capabilities. Avionics systems designs and develops cockpit systems integration and avionics solutions for commercial and military applications. Control systems designs and manufactures technology interface systems for military and commercial aircraft and land- and sea-based military vehicles. Interface technologies manufactures and develops custom control panels, input systems for medical, industrial, military and gaming industries. Communication systems designs and manufactures military audio and data products for severe battlefield environments, embedded communication intercept receivers for signal intelligence applications, as well as communication control systems to enhance security and aural clarity in military applications.

The Sensors & Systems segment includes power systems, connection technologies and advanced sensors capabilities. Power systems develops and manufactures electrical power switching and other related systems, principally for aerospace and defense customers. Connection technologies develops and manufactures highly engineered connectors for harsh environments and serves the aerospace, defense & space, power generation, rail and industrial equipment markets. Advanced sensors develops and manufactures high precision temperature and pressure sensors for aerospace and defense customers.

The Advanced Materials segment includes engineered materials and defense technologies capabilities. Engineered materials develops and manufactures thermally engineered components and high-performance elastomer products used in a wide range of commercial aerospace and military applications. Defense technologies develops and manufactures combustible ordnance components and warfare countermeasure devices for military customers. Sales in all segments include domestic, international, defense and commercial customers.

Our current business and strategic plan focuses on the continued development of our products principally for aerospace and defense markets. We are concentrating our efforts to expand our capabilities in these markets and to anticipate the global needs of our customers and respond to such needs with comprehensive solutions. These efforts focus on continuous research and new product development, acquisitions and strategic realignments of operations to expand our capabilities as a more comprehensive supplier to our customers across our entire product offering.

Net income was $25.1 million, or $0.80 per diluted share, in the first fiscal quarter of 2013 compared with $22.8 million, or $0.73 per diluted share, in the prior-year period.

Total sales decreased 2.7% over the prior-year period to $458.0 million, principally reflecting lower sales in Avionics & Controls and the Advanced Materials segment. These two segments were impacted by reductions in defense spending mainly due to the continued uncertainty of U.S. congressional budget cuts, or sequestration, on defense spending. Without additional congressional action, further budget cuts as set forth in the Budget Control Act of 2011 will be implemented on March 1, 2013. While we believe we have adequately anticipated the impact on our financial results for fiscal 2013, the impact of sequestration is yet to be fully determined and additional reductions in defense spending over the next decade could occur.

Gross margin increased to 35.0% in the first fiscal quarter of 2013 compared with 33.6% in the prior-year period. The prior-year period included effects of purchase accounting to recognize the fair value of the Souriau Group (Souriau) acquired inventory as expense over the first inventory turn. Research, development and engineering spending decreased $3.3 million over the prior-year period to 5.0% of sales due to decreased spending for Avionics & Controls developments. Selling, general and administrative expenses increased $3.9 million over the prior-year period, reflecting a $3.6 million increase in corporate expense. Selling, general and administrative expense as a percent of sales increased 1.4 percentage points over the prior-year period to 21.5% of sales. The increase in selling, general and administrative expense as a percent of sales mainly reflected lower sales volumes. Net income benefited from a decrease in the income tax rate to 8.5% from 10.1% in the prior-year period, reflecting certain discrete tax benefits.

 

24


Operating results for Avionics & Controls and Advanced Materials segments declined while Sensors & Systems improved compared to the prior-year period. The decrease in Avionics & Controls reflected lower sales of avionics systems. The decrease in Advanced Materials mainly reflected lower earnings from sales of engineered materials for defense applications. The increase in Sensors & Systems reflected a prior-year period charge of $12.0 million due to recording Souriau’s acquired inventory at its fair value.

Results of Operations

Three Month Period Ended January 25, 2013, Compared with Three Month Period Ended January 27, 2012

Sales for the first fiscal quarter decreased 2.7% when compared with the prior-year period. Sales by segment were as follows:

(In thousands)

        Incr./(Decr.)       Three Months Ended  
    from prior
year period
      January 25,    
2013
        January 27,    
2012
 

Avionics & Controls

  (2.8)%   $ 174,570      $ 179,572   

Sensors & Systems

  0.1%     171,810        171,672   

Advanced Materials

  (6.7)%     111,582        119,638   
   

 

 

   

 

 

 

Total Net Sales

    $ 457,962      $ 470,882   
   

 

 

   

 

 

 

The 2.8% decrease in sales of Avionics & Controls reflected decreased sales volumes of avionics systems of $6 million and communication systems of $3 million, partially offset by increased sales volumes of control systems. The decrease in avionics systems was principally due to a relative equal decline in cockpit integration and aviation product sales volumes. The decrease in cockpit integration sales reflected a reduction in retrofits for military transport aircraft and the T-6B. The decrease in avionics products mainly reflected the timing of orders and shipments from our defense customers. The decrease in communication systems principally reflected reduced sales of embedded communication intercept receivers. The increase in control systems mainly reflected strong commercial aviation demand.

The 6.7% decrease in sales of Advanced Materials principally reflected decreased sales volumes of defense technologies of $6 million and decreased sales volumes of engineered materials. The decrease in defense technologies sales volumes mainly reflected lower sales of countermeasure devices due to production inefficiencies resulting in delayed shipments. The decrease in engineered materials mainly reflected lower demand for defense applications.

Overall, gross margin was 35.0% and 33.6% for the first fiscal quarter of 2013 and 2012, respectively. Gross profit was $160.3 million and $158.1 million for the first fiscal quarter of 2013 and 2012, respectively.

Avionics & Controls segment gross margin was 36.6% and 38.8% for the first fiscal quarter of 2013 and 2012, respectively. Segment gross profit was $63.8 million compared to $69.7 million in the prior-year period. The decrease in segment gross profit was principally due to lower gross profit on avionics systems of $6 million mainly due to lower sales volumes for the T-6B military trainer cockpit and avionics products for defense applications. A $3 million increase in gross profit on control systems was offset by a decrease in communication systems due to lower demand for embedded communication intercept receivers.

Sensors & Systems segment gross margin was 36.5% and 28.5% for the first fiscal quarter of 2013 and 2012, respectively. Segment gross profit was $62.7 million compared to $48.8 million in the prior-year period. The increase in gross profit was mainly due to increased gross profit for connection technologies of $14 million. The prior-year period gross profit of connection technologies was impacted by a $12 million charge due to recording Souriau’s acquired inventory at its fair value.

 

25


Advanced Materials segment gross margin was 30.3% compared to 33.0% for the prior-year period. Segment gross profit was $33.8 million compared to $39.5 million in the prior-year period. The decrease in segment gross profit was principally due to a $4 million reduction in gross profit on decreased sales of elastomer materials for defense applications. The decrease in gross profit on sales of defense technologies was due to lower sales and production inefficiencies of flare countermeasures.

Selling, general and administrative expenses (which include corporate expenses) totaled $98.6 million, or 21.5% of sales, and $94.7 million, or 20.1% of sales, for the first fiscal quarter of 2013 and 2012, respectively. The 1.4 percentage point increase in selling, general and administrative expense as a percentage of sales was principally due to lower sales volumes. The $3.9 million increase in selling, general and administrative expenses mainly reflected higher corporate compensation expense and professional fees for regulatory compliance and acquisitions.

Research, development and engineering spending was $23.1 million, or 5.0% of sales, for the first fiscal quarter of 2013 compared with $26.4 million, or 5.6% of sales, for the first fiscal quarter of 2012. The decrease in research, development and engineering spending principally reflects lower spending on avionics systems. Fiscal 2013 research, development and engineering spending is expected to be in the range of approximately 5% to 5.25% of sales.

Segment earnings (operating earnings excluding corporate expenses and other income or expense) for the first fiscal quarter of 2013 totaled $55.2 million, or 12.1% of sales, compared with $50.0 million, or 10.6% of sales, for the first fiscal quarter in 2012.

Avionics & Controls segment earnings were $18.6 million, or 10.6% of sales, in the first fiscal quarter of 2013 and $20.1 million, or 11.2% of sales, in the first fiscal quarter of 2012, mainly reflecting a $3 million decrease in avionics systems and a $2 million decrease in communication systems, partially offset by an increase in control systems. Avionics systems earnings were impacted by decreased gross profit, partially offset by lower spending on research, development and engineering. Communication systems earnings were mainly impacted by decreased gross profit on lower sales of embedded communication intercept receivers.

Sensors & Systems segment earnings were $19.0 million, or 11.1% of sales, for the first fiscal quarter of 2013 compared with $6.8 million, or 4.0% of sales, for the first fiscal quarter of 2012, principally reflecting the $12.0 million inventory fair value charge discussed above. Sensors & Systems also benefited by strong earnings from increased sales of power systems, partially offset by weaker earnings from decreased sales of advanced sensors for the aftermarket.

Advanced Materials segment earnings were $17.6 million, or 15.8% of sales, for the first fiscal quarter of 2013 compared with $23.1 million, or 19.3% of sales, for the first fiscal quarter of 2012, primarily reflecting decreased gross profit on lower sales of elastomer materials for defense applications.

Interest expense for the first fiscal quarter of 2013 was $10.4 million compared with $11.5 million for the first fiscal quarter of 2012, reflecting lower borrowings.

The income tax rate was 8.5% compared with 10.1% for the first fiscal quarter of 2013 and 2012, respectively. In the first fiscal quarter of 2013, the Company recognized $3.7 million of discrete tax benefits principally related to the following items. The first item was approximately $1.5 million of tax benefits due to the retroactive extension of the U.S. federal research and experimentation credits. The second item was approximately $2.2 million of tax benefits related to the settlement of U.S. and foreign tax examinations. In the first fiscal quarter of 2012, the Company recognized $2.3 million of discrete tax benefits due to a change in French tax laws associated with the holding company structure and the financing of the Souriau acquisition. The income tax rate differed from the statutory rate in the first fiscal quarter of 2013 and 2012, as both years benefited from various tax credits and certain foreign interest expense deductions.

It is reasonably possible that within the next twelve months approximately $5.1 million of tax benefits associated with research and development tax credits, capital and operating losses that are currently unrecognized could be recognized as a result of settlement of examinations and/or the expiration of a statute of limitations.

 

26


To the extent that sales are transacted in a currency other than the functional currency of the operating unit, we are subject to foreign currency fluctuation risk.

We use forward contracts to hedge our foreign currency exchange risk. To the extent that these hedges qualify under U.S. GAAP, the amount of gain or loss is deferred in Accumulated Other Comprehensive Income (AOCI) until the related sale occurs. Also, we are subject to foreign currency gains or losses from embedded derivatives on backlog denominated in a currency other than the functional currency of our operating companies or its customers. Gains and losses on forward contracts, embedded derivatives, and revaluation of assets and liabilities denominated in a currency other than the functional currency of the Company for the first fiscal quarter of 2013 and 2012 are as follows:

 

(In thousands)             
     Three Months Ended  
         January 25,    
2013
        January 27,    
2012
 

Forward foreign currency contracts – loss

   $ (905   $ (5,803

Forward foreign currency contracts – reclassified from AOCI

     (80     (101

Embedded derivatives – gain

     496        337   

Revaluation of monetary assets/liabilities – gain (loss)

     (3,113     3,351   
  

 

 

   

 

 

 

Total

   $ (3,602   $ (2,216
  

 

 

   

 

 

 

New orders for the first fiscal quarter of 2013 were $473.6 million compared with $467.8 million for the same period in 2012. Backlog was $1.3 billion at January 25, 2013, compared to $1.2 billion at January 27, 2012, and $1.3 billion at the end of fiscal 2012.

 

27


Liquidity and Capital Resources

Cash and cash equivalents at January 25, 2013, totaled $202.8 million, an increase of $42.1 million from October 26, 2012. Net working capital increased to $664.7 million at January 25, 2013, from $639.3 million at October 26, 2012. Sources and uses of cash flows from operating activities principally consisted of cash received from the sale of products and cash payments for material, labor and operating expenses. Cash flows provided by operating activities were $86.5 million and $46.6 million in the first fiscal quarter of 2013 and 2012, respectively. The increase principally reflected high cash receipts from the sale of products.

Cash flows used by investing activities were $12.2 million and $12.5 million in the first fiscal quarter of 2013 and 2012, respectively. Cash flows used by investing activities in the first fiscal quarter of 2013 and 2012 mainly reflected cash paid for capital expenditures.

Cash flows used by financing activities were $32.4 million in the first fiscal quarter of 2013 and mainly reflected $36.6 million repayment of long-term debt. Cash flows used by financing activities were $22.1 million in the first fiscal quarter of 2012 and mainly reflected $28.3 million repayment of long-term debt and government assistance payments received of $7.9 million.

Capital expenditures, consisting of machinery, equipment and computers, are anticipated to be approximately $80.0 million during fiscal 2013, compared with $49.4 million expended in fiscal 2012.

Total debt at January 25, 2013, was $814.4 million and consisted of $250.0 million of Senior Notes due in 2020, $175.0 million of Senior Notes due in 2017, $61.2 million (€45.4 million) of the Euro Term Loan, $225.0 million in borrowings under our secured credit facility, $52.0 million government refundable advances, $44.8 million under capital lease obligations, and $6.4 million under our various foreign currency debt agreements and other debt agreements. On February 5, 2013, the $75.0 million interest rate swap agreement to exchange the fixed interest rate on the $175.0 million Senior Notes due in 2017 for a variable interest rate was called and is payable in 30 days.

Subsequent to period end, on February 4, 2013, we acquired the Gamesman Group (Gamesman) for approximately $39.9 million. Gamesman is a global supplier of input devices principally serving the gaming industry. Gamesman will be included in the Avionics & Controls segment.

We believe cash on hand and funds generated from operations are adequate to service operating cash requirements and capital expenditures through the next twelve months.

Forward-Looking Statements

This quarterly report on Form 10-Q contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “should” or “will” or the negative of such terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risk factors set forth in “Forward-Looking Statements” and “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended October 26, 2012, that may cause our or the industry’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. You should not place undue reliance on these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included or incorporated by reference into this report are made only as of the date hereof. We do not undertake and specifically decline any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments.

 

28


Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes in our exposure to market risk during the first three months of fiscal 2013. A discussion of our exposure to market risk is provided in the Company’s Annual Report on Form 10-K for the fiscal year ended October 26, 2012.

 

Item 4. Controls and Procedures

Our principal executive and financial officers evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of January 25, 2013. Based upon that evaluation, they concluded as of January 25, 2013, that our disclosure controls and procedures were effective to ensure that information we are required to disclose in the reports that we file under the Exchange Act is recorded, processed, summarized and reported within time periods specified in Securities and Exchange Commission rules and forms. In addition, our principal executive and financial officers concluded as of January 25, 2013, that our disclosure controls and procedures are also effective to ensure that information required to be disclosed in reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including to our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

During the time period covered by this report, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

29


PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

From time to time we are involved in legal proceedings arising in the ordinary course of business. We believe that adequate reserves for these liabilities have been made and that there is no litigation pending that could have a material adverse effect on our results of operations and financial condition.

 

Item 6. Exhibits

 

    3.1   Amended and Restated Bylaws of the Company, effective December 13, 2012. (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on
Form 8-K filed on December 18, 2012 [Commission File Number 1-6357].)
  10.1*   Esterline Technologies Corporation Fiscal Year 2013 Annual Incentive Compensation Plan.
  10.2*   Esterline Technologies Corporation Long-Term Incentive Plan.
  10.3*   Form of Global Stock Option Agreement under the Esterline Technologies Corporation Amended and Restated 2004 Equity Incentive Plan.
  10.4*   Form of Restricted Stock Unit Agreement under the Esterline Technologies Corporation Amended and Restated 2004 Equity Incentive Plan.
  10.5*   Promotion Letter from Esterline Technologies Corporation to Marcia Mason dated August 1, 2012.
  10.6*   Promotion Letter from Esterline Technologies Corporation to Albert Yost dated November 16, 2009.
  10.7   Letter Agreement, dated December 13, 2012, among Esterline Technologies Corporation, Relational Investors, LLC and the other parties named in the Letter Agreement. (Incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K dated December 18, 2012 [Commission File Number 1- 6357].)
  11   Schedule setting forth computation of basic and diluted earnings per common share for the three month periods ended January 25, 2013, and January 27, 2012.
  31.1   Certification of Chief Executive Officer.
  31.2   Certification of Chief Financial Officer.
  32.1   Certification (of R. Bradley Lawrence) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32.2               Certification (of Robert D. George) pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

30


Item 6. Exhibits

 101.INS

   XBRL Instance Document   

 101.SCH

   XBRL Taxonomy Extension Schema   

 101.CAL

   XBRL Taxonomy Extension Calculation Linkbase   

 101.DEF

   XBRL Taxonomy Extension Definition Linkbase   

 101.LAB

   XBRL Taxonomy Extension Label Linkbase   

 101.PRE    

   XBRL Taxonomy Extension Presentation Linkbase   

 

 

  

* Indicates management contract or compensatory plan or arrangement.

 

31


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

ESTERLINE TECHNOLOGIES CORPORATION

   

                                 (Registrant)

 
Dated: March 1, 2013     By:    

/s/ Robert D. George

 
      Robert D. George  
      Chief Financial Officer, Vice President, and  
      Corporate Development  
      (Principal Financial Officer)  

 

32